When someone has a heart attack, lowering body temperature can prevent brain damage, so can cooling the brain itself.
RhinoChill brain freeze allows first responders in emergency situations to improve survivability in their patients by applying a chilling nose spray to cool the brain on site.
BeneChill created the RhinoChill device based on technology that has been developed over the past decade. The San Diego company has run clinical trials and is hoping to start selling the device in Europe this summer. FDA approval will take about two years.
Cryogenic First Aid
Rhinochill Brain Freeze Prevents Damage and Death
Trend Themes
1. Cryogenic First Aid - Applying cryogenic technology in emergency situations can prevent brain damage and improve patient survivability.
2. Brain Cooling Devices - Innovative brain cooling devices like RhinoChill are disrupting traditional methods of preventing brain damage in emergency situations.
3. Clinical Trials - Companies like BeneChill are conducting clinical trials to test the efficacy of cryogenic technology in emergency medical procedures.
Industry Implications
1. Medical Devices - The medical device industry has the opportunity to develop and market brain cooling devices like RhinoChill to improve patient outcomes in emergency situations.
2. Emergency Medicine - In the field of emergency medicine, cryogenic first aid techniques have the potential to revolutionize the way brain damage is prevented and treated.
3. Pharmaceutical - Pharmaceutical companies have the opportunity to partner with cryogenic technology companies to develop effective cooling nose sprays for emergency medical use.